These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 20368815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants.
    Poirot E, Vittinghoff E, Ishengoma D, Alifrangis M, Carneiro I, Hashim R, Baraka V, Mosha J, Gesase S, Chandramohan D, Gosling R.
    PLoS One; 2015; 10(11):e0142414. PubMed ID: 26599634
    [Abstract] [Full Text] [Related]

  • 5. Intermittent preventive treatment for malaria in infants.
    Esu EB, Oringanje C, Meremikwu MM.
    Cochrane Database Syst Rev; 2021 Jul 17; 7(7):CD011525. PubMed ID: 34273901
    [Abstract] [Full Text] [Related]

  • 6. Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania.
    Mutabingwa TK, Muze K, Ord R, Briceño M, Greenwood BM, Drakeley C, Whitty CJ.
    PLoS One; 2009 Jul 17; 4(4):e5138. PubMed ID: 19352498
    [Abstract] [Full Text] [Related]

  • 7. Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants.
    Cairns M, Gosling R, Carneiro I, Gesase S, Mosha JF, Hashim R, Kaur H, Lemnge M, Mosha FW, Greenwood B, Chandramohan D.
    PLoS One; 2010 Mar 01; 5(3):e9467. PubMed ID: 20209126
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency.
    Fanello CI, Karema C, Avellino P, Bancone G, Uwimana A, Lee SJ, d'Alessandro U, Modiano D.
    PLoS One; 2008 Mar 01; 3(12):e4031. PubMed ID: 19112496
    [Abstract] [Full Text] [Related]

  • 10. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J, Sismanidis C, Goodman T, Milligan P, WHO Advisory Committee on serological responses to vaccines used in the Expanded Programme on Immunization in infants receiving Intermittent Preventive Treatment for malaria.
    Lancet; 2012 Sep 15; 380(9846):1001-10. PubMed ID: 22850358
    [Abstract] [Full Text] [Related]

  • 11. Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in Ghanaian children: a randomized, placebo controlled trial.
    Kweku M, Liu D, Adjuik M, Binka F, Seidu M, Greenwood B, Chandramohan D.
    PLoS One; 2008 Sep 15; 3(12):e4000. PubMed ID: 19098989
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of chlorproguanil-dapsone with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in young African children: double-blind randomised controlled trial.
    Alloueche A, Bailey W, Barton S, Bwika J, Chimpeni P, Falade CO, Fehintola FA, Horton J, Jaffar S, Kanyok T, Kremsner PG, Kublin JG, Lang T, Missinou MA, Mkandala C, Oduola AM, Premji Z, Robertson L, Sowunmi A, Ward SA, Winstanley PA.
    Lancet; 2004 Jun 05; 363(9424):1843-8. PubMed ID: 15183620
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial.
    Macete E, Aide P, Aponte JJ, Sanz S, Mandomando I, Espasa M, Sigauque B, Dobaño C, Mabunda S, DgeDge M, Alonso P, Menendez C.
    J Infect Dis; 2006 Aug 01; 194(3):276-85. PubMed ID: 16826474
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials.
    Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M, Alonso P, Menendez C.
    Lancet; 2009 Oct 31; 374(9700):1533-42. PubMed ID: 19765816
    [Abstract] [Full Text] [Related]

  • 20. Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants?
    Gosling RD, Ghani AC, Deen JL, von Seidlein L, Greenwood BM, Chandramohan D.
    Malar J; 2008 Apr 03; 7():54. PubMed ID: 18387180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.